7 drugs that raised eyebrows in Q3
7 drugs that raised eyebrows in Q3
Biopharma Dive
Sanofi
Dupixent
Roche
Herceptin
AbbVie
Humira
Regeneron
Repatha
Clovis Oncology
Rubraca
GSK
Shingrix
Eli Lilly
Trulicity
Flag link:
Repeat violations stack up at Dr. Reddy's cancer drug plant
Repeat violations stack up at Dr. Reddy's cancer drug plant
Fierce Pharma
Dr Reddy's
India
FDA
drug manufacturing
Flag link:
Mallinckrodt Gets FDA Committee Vote for Abuse-Deterrent Drug
Mallinckrodt Gets FDA Committee Vote for Abuse-Deterrent Drug
Yahoo/Zacks.com
Mallinckrodt
SpecGx
MNK-812
FDA
Roxicodone
Flag link:
GE Recalls Nearly 1,000 Diagnostic Imaging Systems Due to Detachment Risk
GE Recalls Nearly 1,000 Diagnostic Imaging Systems Due to Detachment Risk
Medical Devices and Diagnostics Industry
devices
GE Healthcare
Millennium Nuclear Medical Systems
recalls
Flag link:
Novartis Calls for FDA Enforcement Against Biosimilar Misinformation
Novartis Calls for FDA Enforcement Against Biosimilar Misinformation
RAPS.org
Novartis
FDA
biosimilars
citizen petitions
Flag link:
Arena’s Comeback Continues with $800M Deal for Blood Disease Drug
Arena’s Comeback Continues with $800M Deal for Blood Disease Drug
Xconomy
Arena Pharmaceuticals
United Therapeutics
PAH
ralinepag
Flag link:
Medtech pins tax repeal hopes on a lame duck
Medtech pins tax repeal hopes on a lame duck
Mass Device
devices
medical device tax
Senate
Flag link:
AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win
AbbVie's Orilissa makes its uterine fibroids case with double phase 3 win
Fierce Pharma
AbbVie
Orilissa
FDA
uterine fibroids
Neurocrine
Flag link:
Lilly's third-to-market Emgality nets FDA 'breakthrough' in cluster headache
Lilly's third-to-market Emgality nets FDA 'breakthrough' in cluster headache
Fierce Pharma
Eli Lilly
Emgality
cluster headaches
FDA
breakthrough therapies
Flag link:
November 15 2018 - Novartis says it won’t spinoff Sandoz unit
Flag link:
Novartis 'completely committed' to Sandoz, has no split-off plan
Novartis 'completely committed' to Sandoz, has no split-off plan
Yahoo/Reuters
Novartis
Sandoz
generics
Flag link:
Pfizer falls short in U.K. patent appeal for blockbuster Lyrica
Pfizer falls short in U.K. patent appeal for blockbuster Lyrica
Fierce Pharma
Pfizer
patents
UK
Lyrica
Flag link:
UCB Debuts AI Powered Virtual Assistant Parkinson's Disease App
UCB Debuts AI Powered Virtual Assistant Parkinson's Disease App
CP WIre
UCB Pharma
Parkinson's Disease
artificial intelligence
mobile apps
Flag link:
AbbVie enlists protein degradation experts at Mission for a new bet on Alzheimer's, Parkinson's
AbbVie enlists protein degradation experts at Mission for a new bet on Alzheimer's, Parkinson's
Endpoints
targeted protein degradation
AbbVie
Mission Therapeutics
Alzheimer's disease
Parkinson's Disease
Flag link:
Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million Upfront and $280 Million in Biobucks
Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million Upfront and $280 Million in Biobucks
BioSpace
cancer
R&D
drug development
Boehringer Ingelheim
Epizyme
Flag link:
UniQure’s hemophilia B gene therapy achieves 31% FIX activity
UniQure’s hemophilia B gene therapy achieves 31% FIX activity
Fierce Biotech
uniQure
hemophilia B
gene therapy
FIX-Padula
Flag link:
Cutting-edge biotech Sangamo stock dives 12% after JPMorgan cites ‘growing skepticism’ in downgrade
Cutting-edge biotech Sangamo stock dives 12% after JPMorgan cites ‘growing skepticism’ in downgrade
Marketwatch
Sangamo Therapeutics
Flag link:
Eli Lilly backs away from Bace but not from novel Alzheimer’s targets
Eli Lilly backs away from Bace but not from novel Alzheimer’s targets
EP Vantage
Eli Lilly
drug development
Alzheimer's disease
BACE inhibitors
Flag link:
FDA warns on pain drugs for implantable pumps
FDA warns on pain drugs for implantable pumps
Drug Delivery Business News
FDA
implantable drug pump
painkillers
devices
Flag link:
Merck starts rolling FDA submission for its Ebola vaccine, aiming to finish next year
Merck starts rolling FDA submission for its Ebola vaccine, aiming to finish next year
Fierce Pharma
Merck
vaccines
Congo
ebola virus
Flag link:

Pages